Mario Schlosser
Showing 1–2 of 2 transcripts.
Mario Schlosser: "How to Deal with a 94% Decline in Market Cap" | E1136
Mario Schlosser, Harry Stebbings
Oscar Health founder Mario Schlosser candidly recounts the company's 2021 IPO, the subsequent 94% stock decline, and his personal battle with depression that necessitated stepping down from the CEO role in 2013 in favor of Mark Berlini. This leadership transition marked a strategic shift toward a model where founders relinquish control during crisis phases, driven by Schlosser's analysis that healthcare innovation requires deep domain expertise and operational pragmatism rather than radical disruption. Despite the financial turbulence and psychological toll, Schlosser maintains that the public market experience was essential for building organizational resilience and identifying the specific, often "pedestrian" improvements necessary to navigate the inefficient US healthcare landscape.
- Milken Institute1h 2m
New Players Disrupting the Healthcare and R&D Landscape
Dan Mendelson, Marc Harrison, Thomas Moriarty, Mario Schlosser, Benjamin Seet, Sue Siegel, David Freeman, Jr., Margot Sanger
Industry leaders from Intermountain Healthcare, CVS Health, Oscar Health, ASTAR, and GE Health converge to address the unsustainable trajectory of U.S. and global healthcare costs through a strategic shift from volume-based to value-driven payment models. The discussion highlights critical initiatives including Intermountain's standalone generic drug venture, CVS's integration of pharmacists into community care hubs, and Oscar's full-stack technology infrastructure designed to leverage telemedicine for acute condition management. While these organizations and non-traditional entrants like Amazon and tech giants in Asia drive innovation, they simultaneously navigate systemic barriers such as data interoperability failures, consumer financial toxicity, and the complex challenge of scaling digital adoption across diverse demographics.